July 2021 in “Journal of dermatology research and therapy” COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.
July 2021 in “Al-Azhar Assiut Medical Journal” Low ferritin, vitamin D deficiency, and thyroid problems may contribute to hair loss in some hospital patients in Western Saudi Arabia.
May 2021 in “Journal of the American College of Cardiology” An 11-year-old girl with Kawasaki disease experienced hair loss that improved after treatment.
Hair loss after weight loss surgery can improve over time.
February 2021 in “INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH” Low zinc and copper levels may indicate Telogen Effluvium.
January 2021 in “Turkiye Klinikleri Journal of Dermatology” Women with a certain type of hair loss had lower levels of a hormone called prolactin compared to healthy women.
January 2021 in “American Academy of PediatricsItasca, IL eBooks” Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.
January 2021 in “Hair therapy & transplantation” Telogen effluvium causes temporary hair loss, but new hair still grows.
COVID-19 may increase hair loss, and Nourkrin® could help treat it.
December 2020 in “Journal of Pakistan Association of Dermatology” COVID-19 recovery can lead to temporary hair loss called telogen effluvium.
December 2020 in “Journal of Drugs in Dermatology” The document concludes that more research is needed to confirm if blood tests for things like iron and vitamin D are helpful for hair loss from Telogen effluvium.
September 2020 in “Osmangazi tıp dergisi” Thyroid dysfunction, vitamin D and B12 deficiencies, and iron deficiency may be linked to hair loss condition Telogen Effluvium.
September 2020 in “University of Thi-Qar Journal of Medicine” Low iron and vitamin D3 levels might be major causes of hair loss in Iraqi women.
February 2020 in “Definitions” Telogen Effluvium is a condition where more hair than usual falls out after stress or fever.
January 2020 in “Nihon rinsho hifukaikai zasshi” A woman's temporary hair loss was caused by high prolactin levels from her medication.
September 2019 in “Journal of Investigative Dermatology” Sandalore, a synthetic scent, was found to reduce hair loss and improve hair growth in women with hair shedding issues.
August 2019 in “Journal of The American Academy of Dermatology” RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.
August 2019 in “DOAJ (DOAJ: Directory of Open Access Journals)” Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.
July 2019 in “International journal of dermatology, venereology and leprosy sciences” Patients with Telogen effluvium have higher levels of heavy metals than healthy individuals.
June 2019 in “Journal of Medical Sciences” Low serum ferritin levels are linked to hair loss in women.
April 2019 in “Journal of Investigative Dermatology” Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.
March 2019 in “Zenodo (CERN European Organization for Nuclear Research)” Both Ayurvedic treatments improved hair fall, with Shirodhara being especially effective.
January 2019 in “SAGE Open Medical Case Reports” A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.
January 2019 in “Jui rinsho hifuka” A dog's hair loss was caused by a hormone-secreting testicular tumor.
October 2018 in “International journal of clinical & experimental dermatology” Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.
August 2018 in “Journal of The American Academy of Dermatology” People with telogen effluvium and scalp discomfort might have low vitamin B12 and could benefit from B12 supplements.
July 2018 in “Elsevier eBooks” Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.
April 2018 in “Journal of Investigative Dermatology” Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.
March 2018 in “Benha Journal of Applied Sciences” Women with telogen effluvium have lower levels of VEGF, which may contribute to their hair loss.
January 2018 in “The Sewanee Review” The poem reflects on hair loss, health concerns, and introspection.